Filing Details
- Accession Number:
- 0000899243-21-045409
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-19 17:15:55
- Reporting Period:
- 2021-11-17
- Accepted Time:
- 2021-11-19 17:15:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1588972 | Recro Pharma Inc. | REPH | Pharmaceutical Preparations (2834) | 261523233 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1846245 | Charles James Miller | C/O Recro Pharma, Inc. 1 E Uwchlan Ave, Suite 112 Exton PA 19341 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-17 | 1,000 | $1.69 | 27,923 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
